Enter your email address:

Delivered by FeedBurner

Mumbai based IPCA gets a shot in the arm as USFDA suspends import ban for key Covid-19 drug

IPCA has a market share of nearly 70% of these drugs, as it is one of
the largest suppliers of the active pharmaceutical ingredient of these
medicines to several large multinational drug companies. Since the
Covid-19 outbreak the company has supplied nearly 5 lakh tablets
across the world.



Post a Comment